A. M. Liberati

2.2k total citations
20 papers, 689 citations indexed

About

A. M. Liberati is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, A. M. Liberati has authored 20 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Pathology and Forensic Medicine and 8 papers in Oncology. Recurrent topics in A. M. Liberati's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CAR-T cell therapy research (3 papers). A. M. Liberati is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and CAR-T cell therapy research (3 papers). A. M. Liberati collaborates with scholars based in Italy, Germany and France. A. M. Liberati's co-authors include Wolfgang Knauf, Liana Gercheva, Peter Klein, Ilaria Del Giudice, Ali Aldaoud, Françoise Huguet, K Merkle, Gerhard Postner, Vesselina Goranova‐Marinova and Raoul Herbrecht and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

A. M. Liberati

19 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. M. Liberati Italy 11 480 363 201 158 127 20 689
Luciano Levato Italy 13 440 0.9× 257 0.7× 268 1.3× 189 1.2× 128 1.0× 39 659
Gerhard Postner Austria 7 354 0.7× 324 0.9× 109 0.5× 127 0.8× 61 0.5× 8 613
Liana Gercheva Bulgaria 15 707 1.5× 417 1.1× 765 3.8× 209 1.3× 194 1.5× 46 1.3k
Filiz Şen United States 16 163 0.3× 278 0.8× 117 0.6× 124 0.8× 213 1.7× 42 623
Alain Sadoun France 12 209 0.4× 158 0.4× 432 2.1× 142 0.9× 249 2.0× 28 820
J.J. Sotto France 11 186 0.4× 238 0.7× 148 0.7× 125 0.8× 178 1.4× 17 565
Elaine Murray United States 9 154 0.3× 187 0.5× 123 0.6× 200 1.3× 198 1.6× 11 716
Antònia Sampol Spain 14 153 0.3× 147 0.4× 430 2.1× 161 1.0× 189 1.5× 60 731
H Urbańska-Ryś Poland 12 197 0.4× 156 0.4× 133 0.7× 99 0.6× 159 1.3× 24 449
Christina Nickenig Germany 11 200 0.4× 378 1.0× 90 0.4× 73 0.5× 272 2.1× 20 569

Countries citing papers authored by A. M. Liberati

Since Specialization
Citations

This map shows the geographic impact of A. M. Liberati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Liberati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Liberati more than expected).

Fields of papers citing papers by A. M. Liberati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Liberati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Liberati. The network helps show where A. M. Liberati may publish in the future.

Co-authorship network of co-authors of A. M. Liberati

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Liberati. A scholar is included among the top collaborators of A. M. Liberati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Liberati. A. M. Liberati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salles, Gilles, Johannes Duell, Eva González‐Barca, et al.. (2019). PRIMARY ANALYSIS RESULTS OF THE SINGLE‐ARM PHASE II STUDY OF MOR208 PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (L‐MIND). Hematological Oncology. 37(S2). 173–174. 4 indexed citations
2.
Malapelle, Umberto, Biagio Ricciuti, Sara Baglivo, et al.. (2018). Osimertinib. Recent results in cancer research. 211. 257–276. 30 indexed citations
3.
Duell, Johannes, Eva González‐Barca, A. M. Liberati, et al.. (2017). L-MIND: MOR208 combined with lenalidomide (LEN) in patients with relapsed or refractory diffuse large B-cell lymphoma (R-R DLBCL) - a single-arm phase II study. 1 indexed citations
4.
Salles, Gilles, Eva González‐Barca, Wojciech Jurczak, et al.. (2017). L‐MIND: MOR208 COMBINED WITH LENALIDOMIDE (LEN) IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R‐R DLBCL) – A SINGLE‐ARM PHASE II STUDY. Hematological Oncology. 35(S2). 51–52. 1 indexed citations
5.
Al‐Ali, Haifa Kathrin, Martin Grießhammer, Philipp le Coutre, et al.. (2016). Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial. Haematologica. 101(9). 1065–1073. 119 indexed citations
6.
7.
Knauf, Wolfgang, Toshko Lissitchkov, Ali Aldaoud, et al.. (2012). Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial. British Journal of Haematology. 159(1). 67–77. 77 indexed citations
8.
Falchi, Lorenzo, et al.. (2011). High-dose methotrexate, temozolomide, and intrathecal liposomal cytarabine (HD-MTX-TMZ-IT LC), without radiotherapy for central nervous system (CNS) lymphoma.. Journal of Clinical Oncology. 29(15_suppl). e18555–e18555. 1 indexed citations
9.
Knauf, Wolfgang, Toshko Lissitchkov, Ali Aldaoud, et al.. (2009). Bendamustine in the Treatment of Chronic Lymphocytic Leukemia -Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups.. Blood. 114(22). 2367–2367. 10 indexed citations
10.
Knauf, Wolfgang, Ali Aldaoud, A. M. Liberati, et al.. (2009). Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 27(26). 4378–4384. 304 indexed citations
11.
12.
Merli, Francesco, M Bertini, Stefano Luminari, et al.. (2007). Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 48(2). 367–373. 18 indexed citations
13.
Revoltella, Roberto P., Leopoldo Laricchia‐Robbio, Stefania Moscato, et al.. (2001). Naturally-occurring anti-G-CSF antibodies produced by human cord blood B-cell lines infected with Epstein-Barr virus. The Hematology Journal. 2(3). 161–171. 2 indexed citations
14.
Calabrese, Giuseppe, Liborio Stuppia, Paolo Guanciali Franchi, et al.. (1994). Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genetics and Cytogenetics. 78(2). 153–159. 39 indexed citations
15.
Ferri, Claudio, E Marzo, G. Longombardo, et al.. (1993). Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial.. Gut. 34(2 Suppl). S144–S145. 15 indexed citations
16.
Liberati, A. M., Michel A. Horisberger, Lucia Palmisano, et al.. (1992). Double-Blind Randomized Phase I Study on the Clinical Tolerance and Biological Effects of Natural and Recombinant Interferon-β. Journal of Interferon Research. 12(5). 329–336. 26 indexed citations
17.
Liberati, A. M., et al.. (1991). Phase I-II trial on natural beta interferon in chemoresistant and relapsing multiple myeloma.. PubMed. 75(5). 436–42. 6 indexed citations
18.
Liberati, A. M., et al.. (1989). A Phase I Study of Human Natural Interferon-β in Cancer Patients. Journal of Interferon Research. 9(3). 339–348. 11 indexed citations
19.
Liberati, A. M., Enzo Ballatori, Marco Fizzotti, et al.. (1988). A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission. Cancer Immunology Immunotherapy. 26(1). 87–93. 6 indexed citations
20.
Liberati, A. M., Enzo Ballatori, Marco Fizzotti, et al.. (1987). Immunologic profile in patients with Hodgkin's disease in complete remission. Cancer. 59(11). 1906–1913. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luciano Levato Breakdown of academic impact, for papers by Gerhard Postner Breakdown of academic impact, for papers by Liana Gercheva Breakdown of academic impact, for papers by Filiz Şen Breakdown of academic impact, for papers by Alain Sadoun Breakdown of academic impact, for papers by J.J. Sotto Breakdown of academic impact, for papers by Elaine Murray Breakdown of academic impact, for papers by Antònia Sampol Breakdown of academic impact, for papers by H Urbańska-Ryś Breakdown of academic impact, for papers by Christina Nickenig
Rankless by CCL
2026